< Back to previous page
Researcher
Marc Van Ranst
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2005 → 31 Dec 2006 - Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 29
- Environmental sampling as a tool to monitor enteric virus epidemiologyFrom1 Feb 2023 → TodayFunding: FWO fellowships
- SDS/EDTA-treated chromatography paper strips for laboratory confirmation of monkeypox virus in the context of the global mpox epidemiologyFrom2 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The assessment of virome composition and dynamic in blood transfusion settingFrom1 Oct 2020 → 30 Sep 2024Funding: BOF - projects
- Development of a new point-of-care COVID-19 screening using exhaled-breath volatilome analysis.From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
- Microbial Communities in Biomedical and Environmental Areas, and Systems BiologyFrom1 Jan 2018 → 31 Aug 2021Funding: H2020-EU.4. - Spreading excellence and widening participation
- Third generation sequencing and herpesvirus diversity: Towards complete double-stranded DNA virus genomesFrom8 Dec 2017 → 20 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rotavirus in Bats and Humans: Genetic Diversity and Gastroenteritis in the Post-Vaccine EraFrom1 Oct 2017 → 25 Jan 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Metagenomic analysis of the virome of the honeybee (Apis mellifera) in the Czech RepublicFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Bilateral scientific cooperation
- Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training NetworkFrom1 Apr 2017 → 31 Mar 2021Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- Development and application of filovirus reverse genetics systems for antiviral compound screeningFrom1 Jan 2017 → 24 Sep 2021Funding: FWO Strategic Basic Research Grant
Publications
31 - 40 of 358
- A confirmed case of COVID-19 reinfection with a genetically distinct strain: a case report from Belgium(2022)Published in: ACTA CLINICA BELGICAISSN: 1784-3286Issue: 3Volume: 77Pages: 686 - 687
- Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection(2022)Published in: Diagnostic Microbiology and Infectious DiseaseISSN: 0732-8893Issue: 1Volume: 103
- Cytidine nucleoside analog is an effective antiviral drug against Trichomonasvirus(2022)Published in: J Microbiol Immunol InfectISSN: 1684-1182Issue: 2Volume: 55Pages: 191 - 198
- The virota and its transkingdom interactions in the healthy infant gut(2022)Published in: Proceedings of the National Academy of Sciences of the United States of AmericaISSN: 0027-8424Issue: 13Volume: 119
- VALCOR: a protocol for the validation of SARS-corona virus-2 assays(2022)Published in: Archives of Public HealthISSN: 0778-7367Issue: 1Volume: 80
- The influence of COVID-19 on routine hematological parameters of hospitalized patients(2022)Published in: ACTA CLINICA BELGICAISSN: 1784-3286Issue: 2Volume: 77Pages: 241 - 246
- Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian Initiative(2022)Published in: Life-BaselISSN: 2075-1729Issue: 2Volume: 12
- Rotavirus in Bats and Humans: Genetic Diversity and Gastroenteritis in the Post-Vaccine Era(2022)
- Third generation sequencing and herpesvirus diversity: Towards complete double-stranded DNA virus genomes(2021)
- Successional Stages in Infant Gut Microbiota Maturation(2021)Published in: mBioISSN: 2150-7511Issue: 6Volume: 12